Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
687
datasets available to search
ShareScore release 0.9.0
Dataset results
687 results for “MDS”
A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00136461. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of JNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03915379. IPD Sharing: YES. Countries: 3. Publications: 0.
Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01481220. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00225992. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML
ClinicalTrials.gov study NCT00195104. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients
ClinicalTrials.gov study NCT04097470. IPD Sharing: NO. Countries: 4. Publications: 0.
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01065129. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of KHK2823 in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02181699. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02428686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant
ClinicalTrials.gov study NCT03961919. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Italian Network MDS Registry
ClinicalTrials.gov study NCT02808858. IPD Sharing: NO. Countries: 1. Publications: 0.
HCT With PTCy in Higher-risk MDS
ClinicalTrials.gov study NCT06098313. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation
ClinicalTrials.gov study NCT07025824. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of Lower-risk MDS Patients With and Without Improvements in Fatigue Following Blood Transfusion Therapy
ClinicalTrials.gov study NCT04103359. IPD Sharing: NO. Countries: 1. Publications: 0.
HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
ClinicalTrials.gov study NCT06594445. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation
ClinicalTrials.gov study NCT05473910. IPD Sharing: NO. Countries: 1. Publications: 0.
Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regim
ClinicalTrials.gov study NCT02378701. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)
ClinicalTrials.gov study NCT07183878. IPD Sharing: YES. Countries: 1. Publications: 0.
Biocollection in MyeloDysplastic Syndrome (P-MDS)
ClinicalTrials.gov study NCT04869683. IPD Sharing: YES. Countries: 1. Publications: 0.
Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
ClinicalTrials.gov study NCT05636514. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.